Global DNA Methylation Market size is expected to be worth around US$ 6.5 Billion by 2034 from US$ 1.6 Billion in 2024.

A new review in Discover Aging examines how the AP2A1 protein, long known for its role in clathrin-mediated endocytosis, has ...

(NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has expanded approval of TALZENNA ® (talazoparib ...

Leading life scientist Wu Jun, who recently left the United States to return to his homeland, believes many of the world’s ...

Global Toxicology Drug Screening Market was valued at USD 15.94 Bn in 2025 and is expected to grow at 8.42% CAGR to reach USD ...

The broiler chicken is the quintessence of the modern meat complex. In 1925 the average chicken brought to slaughter was 112 ...

Johnson & Johnson (NYSE:JNJ) today announced new results from Cohort 5 of the Phase 1b/2 OrigAMI-4 study showing deep and durable responses with first-line subcutaneous amivantamab and ...

Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's IMFINZI® (durvalumab) reduced the risk of death by 58% ...

The therapeutic options for patients with inflammatory bowel disease (IBD) have recently expanded substantially. Tofacitinib, ...

Acute myeloid leukemia (AML) is marked by unchecked expansion of undifferentiated myeloid cells. Although oncogenic fusions ...